COVID-19: Oxford Vaccine gives out encouraging signals during preliminary clinical trials. Let's hope for the best.
<<ChAdOx1 nCoV-19 showed an acceptable safety profile, and homologous boosting increased antibody responses. These results, together with the induction of both humoral and cellular immune responses, support large-scale evaluation of this candidate vaccine in an ongoing phase 3 programme.>> < https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext > -- You received this message because you are subscribed to the Google Groups "Green Youth Movement" group. To unsubscribe from this group and stop receiving emails from it, send an email to [email protected]. To view this discussion on the web, visit https://groups.google.com/d/msgid/greenyouth/CACEsOZjg_-tyAX4shh-J0r7-ykCJW8W4chbKubq0Qct3qk_VBw%40mail.gmail.com.
